What is the current valuation of the US particle therapy market?

The market valuation was $305.87 Million in 2024. Read More

What is the projected market size for the US particle therapy market by 2035?

The market is projected to reach $710.0 Million by 2035. Read More

What is the expected CAGR for the US particle therapy market during the forecast period 2025 - 2035?

The expected CAGR is 7.96% during the forecast period. Read More

Which companies are the key players in the US particle therapy market?

Key players include Varian Medical Systems, Elekta AB, Hitachi Ltd, Siemens Healthineers, Proton Therapy Solutions, Mevion Medical Systems, Iba Group, and Accuray Incorporated. Read More

What are the main types of particle therapy available in the market?

The main types include Proton Therapy, valued between $200.0 Million and $500.0 Million, and Heavy Ion Therapy, valued between $105.87 Million and $210.0 Million. Read More

What are the primary cancer types treated with particle therapy?

Primary cancer types include Prostate Cancer, Lung Cancer, Pediatric Cancer, Head and Neck Cancer, and Breast Cancer, with valuations ranging from $30.0 Million to $160.0 Million. Read More

What products and services are offered in the US particle therapy market?

Products include Cyclotrons, Synchrotrons, Synchrocyclotrons, and various services, with valuations from $30.0 Million to $320.0 Million. Read More

How are particle therapy systems categorized in the market?

Systems are categorized into Multi-Room Systems, valued between $200.0 Million and $500.0 Million, and Single-Room Systems, valued between $105.87 Million and $210.0 Million. Read More

What applications are driving growth in the US particle therapy market?

Growth is driven by Treatment Applications, valued between $245.0 Million and $550.0 Million, and Research Applications, valued between $60.0 Million and $160.0 Million. Read More

What trends are influencing the US particle therapy market in 2025?

Trends include advancements in technology and increasing demand for effective cancer treatments, contributing to the market's growth. Read More

US Particle Therapy Market

ID: MRFR/MED/13970-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

United States Particle Therapy Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Proton Therapy
  2. 4.1.2 Heavy Ion Therapy
2. 4.2 Medical Device, BY Product and Services (USD Million)
  1. 4.2.1 Cyclotrons
  2. 4.2.2 Synchrotrons
  3. 4.2.3 Synchrocyclotrons
  4. 4.2.4 Services
3. 4.3 Medical Device, BY Cancer Type (USD Million)
  1. 4.3.1 Prostate Cancer
  2. 4.3.2 Lung Cancer
  3. 4.3.3 Pediatric Cancer
  4. 4.3.4 Head and Neck Cancer
  5. 4.3.5 Breast Cancer
  6. 4.3.6 Others
4. 4.4 Medical Device, BY System (USD Million)
  1. 4.4.1 Multi-Room Systems
  2. 4.4.2 Single-Room Systems
5. 4.5 Medical Device, BY Application (USD Million)
  1. 4.5.1 Treatment Applications
  2. 4.5.2 Research Applications
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Varian Medical Systems (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Elekta AB (SE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Hitachi Ltd (JP)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Proton Therapy Solutions (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mevion Medical Systems (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Iba Group (BE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Accuray Incorporated (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY PRODUCT AND SERVICES
4. 6.4 US MARKET ANALYSIS BY CANCER TYPE
5. 6.5 US MARKET ANALYSIS BY SYSTEM
6. 6.6 US MARKET ANALYSIS BY APPLICATION
7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY PRODUCT AND SERVICES, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY PRODUCT AND SERVICES, 2024 TO 2035 (USD Million)
17. 6.17 MEDICAL DEVICE, BY CANCER TYPE, 2024 (% SHARE)
18. 6.18 MEDICAL DEVICE, BY CANCER TYPE, 2024 TO 2035 (USD Million)
19. 6.19 MEDICAL DEVICE, BY SYSTEM, 2024 (% SHARE)
20. 6.20 MEDICAL DEVICE, BY SYSTEM, 2024 TO 2035 (USD Million)
21. 6.21 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
22. 6.22 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT AND SERVICES, 2025-2035 (USD Million)
  3. 7.2.3 BY CANCER TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY SYSTEM, 2025-2035 (USD Million)
  5. 7.2.5 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

Proton Therapy
Heavy Ion Therapy

Medical Device By Product and Services (USD Million, 2025-2035)

Cyclotrons
Synchrotrons
Synchrocyclotrons
Services

Medical Device By Cancer Type (USD Million, 2025-2035)

Prostate Cancer
Lung Cancer
Pediatric Cancer
Head and Neck Cancer
Breast Cancer
Others

Medical Device By System (USD Million, 2025-2035)

Multi-Room Systems
Single-Room Systems

Medical Device By Application (USD Million, 2025-2035)

Treatment Applications
Research Applications

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓